Diphenylazetidinone derivates processing cholesterol absorption inhibitory activity

Details for Australian Patent Application No. 2004303741 (hide)

Owner AstraZeneca AB

Inventors Dahlstrom, Mikael; Skjaret, Tore; Lindqvist, Ann-Margret; Karlsson, Staffan; Hunegnaw, Fana; Starke, Ingemar; Lemurell, Malin; Alenfalk, Susanne

Agent Davies Collison Cave

Pub. Number AU-A-2004303741

PCT Pub. Number WO2005/061451

Priority 0329778.5 23.12.03 GB

Filing date 21 December 2004

Wipo publication date 7 July 2005

International Classifications

C07D 205/08 (2006.01) Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom

Event Publications

29 June 2006 PCT application entered the National Phase

  PCT publication WO2005/061451 Priority application(s): WO2005/061451

27 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004303742-Diphenylazetidinone derivatives possessing cholesterol absorption inhibitory activity

2004303740-Nicotinic acetylcholine receptor ligands